![](/img/cover-not-exists.png)
A 24-Week, Prospective, Randomized, Open-Label, Treat-To-Target Pilot Study of Obese Type 2 Diabetes Patients with Severe Insulin Resistance to Assess the Addition of Exenatide on the Efficacy of U-500 Regular Insulin Plus Metformin
Distiller, Larry, Nortje, Hendrik, Wellmann, Holger, Amod, Aslam, Lombard, LandmanVolume:
20
Language:
english
Journal:
Endocrine Practice
DOI:
10.4158/EP14067.OR
Date:
November, 2014
File:
PDF, 739 KB
english, 2014